Employers are expressing an unprecedented level of interest and actions toward tackling the root causes of escalating costs, according to a trends survey from Hewitt Associates.
Lincolnshire, Il.-Employers are expressing an unprecedented level of interest and actions toward tackling the root causes of escalating costs, according to a trends survey from Hewitt Associates.
"There's a need for more innovative design, network and medical management solutions that reduce cost for employer and participant and move away from simple cost-sharing decisions between employer and employee and get to root cause of healthcare trend," says Tom Beauregard, healthcare strategy leader at Hewitt Associates.
Viable disease management models are needed to control the cost of chronic conditions and improve productivity, Beauregard says.
"Address the need for provider transparency by producing cost and quality measures for hospitals and specialists," Beauregard adds.
- Tracey Walker
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Roflumilast Foam Showed Strong Results for Scalp and Body Psoriasis in Teens and Adults
May 7th 2025A new JAMA Dermatology study found that once-daily Zoryve (roflumilast) foam, 0.3%, safely and effectively reduced scalp and body plaque psoriasis symptoms in patients 12 and older, offering a convenient, and more tolerated treatment option that may boost adherence and quality of life.
Read More